Dr. Scott E. Mintzer, MD

Dr. Mintzer practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Mintzer's NPI, 1811917933, was assigned on July 20, 2006. Dr. Mintzer holds Pennsylvania license MD426312.

Dr. Mintzer's primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000.

Dr. Mintzer's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Mintzer is also affiliated with Jefferson Torresdale Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Mintzer to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mintzer practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mintzer's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mintzer is licensed in Pennsylvania.

CMS data shows 426 Medicare services from Dr. Mintzer across 8 procedure codes in 2024, for 236 Medicare patients. Medicare paid $37,775 for them.

CMS counts 236 Medicare patients who saw Dr. Mintzer in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mintzer's median patient age at 54, with 49% women.

In 2024, Dr. Mintzer wrote 497 Medicare Part D claims for 71 patients. 81% of them were for generic drugs. CMS names the drug for 388 of them, across 15 drugs with 11 or more claims each, at $134,341 in total drug cost. In 2023, CMS named 240 claims across 10 drugs.

Dr. Mintzer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mintzer as offering telehealth.

Dmand AI links 45 papers to Dr. Mintzer, published from 2008 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Anticonvulsants, Epilepsy and Carbamazepine. Dr. Mintzer has published most often in Epilepsia. Dr. Mintzer's most frequent co-authors are Maromi Nei, MD, Christopher T. Skidmore, MD and Carla Francesca Lopinto-Khoury, MD.

CMS Open Payments shows 177 general payments to Dr. Mintzer from 10 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 61% of the total. UCB, Inc. paid the most, $57,436.